Human SNP ID | rs1568679 |
---|---|
Human chromosome | chr15 |
Human SNP position | 37057601 |
Pig chromosome | chr1 |
Pig SNP position | 149933405 |
PubMed ID | 20195266 |
---|---|
Journal | Mol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/20195266 |
Study | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 421 European ancestry, 214 African American, and 103 cases |
Replication sample | NA |
Region | 15q14 |
Chromosome id | chr15 |
Chromosome position | 37057601 |
Reported gene | MEIS2 |
Mapped gene | MEIS2 |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 4212 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs1568679-? |
SNPs | rs1568679 |
Merged | 0 |
SNP id current | 1568679 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | 0.103 |
P value | 0.00000001 |
Pvalue mlog | 8 |
P value text | (risperidone-hip circumference) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to risperidone |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097336 |
Study accession | GCST000618 |